Brontuss
Product Images NDC 49963-813

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Brontuss (NDC 49963-813). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Portal Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Brontuss Sf Packaging (Mm1)

Label for Brontuss SF Liquid, an antitussive, expectorant, and nasal decongestant oral solution. Each 5 mL teaspoonful contains 15 mg Dextromethorphan HBr, 300 mg Guaifenesin, and 10 mg Phenylephrine HCl. The 1 oz (30 mL) bottle is supplied with a child-resistant cap and tamper-evident foil seal. Manufactured for Portal Pharmaceutical, Mayagüez, PR.*

FDA Label Image

Brontuss Sf Packaging (Mm2)

Drug Facts panels for Brontuss SF liquid, listing active ingredients including Dextromethorphan HBr 15 mg, Guaifenesin 300 mg, and Phenylephrine HCl 10 mg per 5 mL teaspoonful. The panels detail uses, directions by age, warnings including interactions with monoamine oxidase inhibitors, inactive ingredients, and storage instructions. Labeler is Portal Inc. in Mayaguez, Puerto Rico.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.